» Articles » PMID: 19089435

Cytotoxic T Lymphocyte Antigen-4 Promoter -658CT Gene Polymorphism is Associated with Ulcerative Colitis in Chinese Patients

Overview
Date 2008 Dec 18
PMID 19089435
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Cytotoxic T lymphocyte antigen-4 (CTLA-4) plays a role in the downregulation of T cell activation. The present study aimed to examine an association between the CTLA-4 gene polymorphisms and ulcerative colitis (UC) in the Han Chinese in central China.

Materials And Methods: One hundred seventeen patients with UC and 246 healthy controls were genotyped for CTLA-4 gene -658CT in the promoter and CT61 at the 3' untranslated region using a method of polymerase chain reaction-based restriction fragment length polymorphism and single-strand conformation polymorphism, respectively. The distributions of the genotypes and the allele frequencies of the CTLA-4 gene in UC patients and healthy controls were compared by chi-square test.

Results: The frequency of the T/T+C/T genotype at the CTLA-4 gene -658CT in the promoter was significantly higher in UC patients than in healthy controls (26.5% vs 15.4%, chi (2) = 6.287, P = 0.015, OR = 1.973, 95%CI = 1.153-3.375). The frequency of the T allele at the CTLA-4 -658CT was also significantly higher in UC patients than in the controls (13.2% vs 8.1%, chi (2) = 4.707, P = 0.033, OR = 1.726, 95%CI = 1.049-2.838). The frequency of the T/T genotype at the -658 locus was highly associated with extensive colitis in UC patients (P = 0.037, OR = 3.955, 95%CI = 1.068-14.647). The frequency of the T allele at the -658 locus was highly associated with extensive colitis in UC patients (P = 0.0067, OR = 3.05, 95%CI = 1.320-7.048).

Conclusion: The T allele of CTLA-4 -658 polymorphism in the promoter of CTLA-4 gene was highly associated with UC in the Han Chinese in central China.

Citing Articles

Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration.

Guri A, Hontecillas R, Bassaganya-Riera J Clin Nutr. 2010; 29(6):824-31.

PMID: 20236740 PMC: 2894983. DOI: 10.1016/j.clnu.2010.02.009.

References
1.
Ligers A, Teleshova N, Masterman T, Huang W, Hillert J . CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2001; 2(3):145-52. DOI: 10.1038/sj.gene.6363752. View

2.
Smyth D, Howson J, Payne F, Maier L, Bailey R, Holland K . Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Genet. 2006; 7:20. PMC: 1420277. DOI: 10.1186/1471-2350-7-20. View

3.
Ueda H, Howson J, Esposito L, Heward J, Snook H, Chamberlain G . Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003; 423(6939):506-11. DOI: 10.1038/nature01621. View

4.
Downie-Doyle S, Bayat N, Rischmueller M, Lester S . Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome. Arthritis Rheum. 2006; 54(8):2434-40. DOI: 10.1002/art.22004. View

5.
Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, Mandelbrot D . Cutting edge: transplantation tolerance through enhanced CTLA-4 expression. J Immunol. 2003; 171(11):5673-7. DOI: 10.4049/jimmunol.171.11.5673. View